Authors:
COVINSKY KE
ROSENTHAL GE
CHREN MM
JUSTICE AC
FORTINSKY RH
PALMER RM
LANDEFELD CS
Citation: Ke. Covinsky et al., THE RELATION BETWEEN HEALTH-STATUS CHANGES AND PATIENT SATISFACTION IN OLDER HOSPITALIZED MEDICAL PATIENTS, Journal of general internal medicine, 13(4), 1998, pp. 223-229
Authors:
ROSENTHAL GE
CHREN MM
LASEK RJ
LANDEFELD CS
Citation: Ge. Rosenthal et al., WHAT PATIENTS SHOULD ASK OF CONSUMERS GUIDES TO HEALTH-CARE QUALITY, Evaluation & the health professions, 21(3), 1998, pp. 316-331
Citation: Am. Polster et al., REPORTS BY PATIENTS AND DERMATOLOGISTS OF SKIN-CANCER PREVENTIVE SERVICES PROVIDED IN DERMATOLOGY OFFICES, Archives of dermatology, 134(9), 1998, pp. 1095-1098
Citation: Rj. Lasek et Mm. Chren, ACNE-VULGARIS AND THE QUALITY-OF-LIFE OF ADULT DERMATOLOGY PATIENTS, Archives of dermatology, 134(4), 1998, pp. 454-458
Citation: Cs. Landefeld et Mm. Chren, PREVENTING DISABILITY IN OLDER-PEOPLE WITH CHRONIC DISEASE - WHAT IS A DOCTOR TO DO, Journal of the American Geriatrics Society, 46(10), 1998, pp. 1314-1316
Citation: Rj. Lasek et Mm. Chren, DOES ACNE-VULGARIS AFFECT THE QUALITY-OF-LIFE OF OLDER PATIENTS MORE THAN YOUNGER PATIENTS, Journal of investigative dermatology, 108(3), 1997, pp. 16-16
Citation: Mm. Chren et Rj. Lasek, SKINDEX1.1 - RELIABILITY, VALIDITY, AND RESPONSIVENESS OF A REFINED INSTRUMENT TO MEASURE THE EFFECTS OF SKIN-DISEASE ON QUALITY-OF-LIFE, Journal of investigative dermatology, 108(3), 1997, pp. 21-21
Citation: Mm. Chren et al., CONVERGENT AND DISCRIMINANT VALIDITY OF A GENERIC AND A DISEASE-SPECIFIC INSTRUMENT TO MEASURE QUALITY-OF-LIFE PATIENTS WITH SKIN-DISEASE, Journal of investigative dermatology, 108(1), 1997, pp. 103-107
Citation: Mm. Chren et al., IMPROVED DISCRIMINATIVE AND EVALUATIVE CAPABILITY OF A REFINED VERSION OF SKINDEX, A QUALITY-OF-LIFE INSTRUMENT FOR PATIENTS WITH SKIN DISEASES, Archives of dermatology, 133(11), 1997, pp. 1433-1440
Authors:
ROSENTHAL GE
CHREN MM
LASEK RJ
LANDEFELD S
Citation: Ge. Rosenthal et al., THE ANNUAL GUIDE TO AMERICA BEST HOSPITALS - EVIDENCE OF INFLUENCE AMONG HEALTH-CARE LEADERS, Journal of general internal medicine, 11(6), 1996, pp. 366-369
Authors:
BEYTH RJ
ANTANI MR
COVINSKY KE
MILLER DG
CHREN MM
QUINN LM
LANDEFELD CS
Citation: Rj. Beyth et al., WHY ISNT WARFARIN PRESCRIBED TO PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION, Journal of general internal medicine, 11(12), 1996, pp. 721-728
Citation: Cs. Landefeld et Mm. Chren, DRUG COMPANIES AND INFORMATION ABOUT DRUGS - RECOMMENDATIONS FOR DOCTORS CHARACTERISTICS OF MATERIALS DISTRIBUTED BY DRUG COMPANIES - 4 POINTS-OF-VIEW, Journal of general internal medicine, 11(10), 1996, pp. 642-644
Authors:
CHREN MM
LASEK RJ
QUINN LM
MOSTOW EN
ZYZANSKI SJ
Citation: Mm. Chren et al., SKINDEX, A QUALITY-OF-LIFE MEASURE FOR PATIENTS WITH SKIN-DISEASE - RELIABILITY, VALIDITY, AND RESPONSIVENESS, Journal of investigative dermatology, 107(5), 1996, pp. 707-713
Citation: Fm. Durden et al., FAT NECROSIS WITH FEATURES OF ERYTHEMA-NODOSUM IN A PATIENT WITH METASTATIC PANCREATIC-CARCINOMA, International journal of dermatology, 35(1), 1996, pp. 39-41
Authors:
WOOD GS
LYNCH WS
DAVIS B
CHREN MM
BAUD E
BRODELL RT
ELEWSKI BE
MARTIN RW
COOPER KD
Citation: Gs. Wood et al., RESTRUCTURING DERMATOLOGY EDUCATION AT CLEVELAND MEDICAL-CENTERS AFFILIATED WITH CASE-WESTERN-RESERVE-UNIVERSITY, Archives of dermatology, 132(9), 1996, pp. 1085-1090
Citation: Ja. Dong et al., BONSAI TREE - RISK FACTOR FOR DISSEMINATED SPOROTRICHOSIS, Journal of the American Academy of Dermatology, 33(5), 1995, pp. 839-840
Citation: Mm. Chren et Cs. Landefeld, THE COST OF TOPICAL DRUGS FOR DERMATOPHYTE INFECTIONS - REPLY, JAMA, the journal of the American Medical Association, 274(1), 1995, pp. 27-27
Authors:
CHREN MM
LAZARUS HM
SALATA RA
LANDEFELD CS
Citation: Mm. Chren et al., CULTURES OF SKIN BIOPSY-TISSUE FROM IMMUNOCOMPROMISED PATIENTS WITH CANCER AND RASHES, Archives of dermatology, 131(5), 1995, pp. 552-555
Citation: Mm. Chren et al., FOLIC-ACID SUPPLEMENTATION WITH METHOTREXATE THERAPY - WHAT BENEFIT IF ANY - REPLY, Journal of the American Academy of Dermatology, 31(4), 1994, pp. 689-689
Citation: Mm. Chren, COSTS OF THERAPY FOR DERMATOPHYTE INFECTIONS, Journal of the American Academy of Dermatology, 31(3), 1994, pp. 190000103-190000106
Citation: Mm. Chren et Cs. Landefeld, PHARMACEUTICAL PROMOTION AND PHYSICIAN REQUESTS TO HOSPITAL FORMULARIES - REPLY, JAMA, the journal of the American Medical Association, 272(5), 1994, pp. 355-355